Zobrazeno 1 - 10
of 1 014
pro vyhledávání: '"M. J. Otto"'
Autor:
Tenzin Wangmo Ba, Pamela B. Teaster
Publikováno v:
Journal of Elder Abuse & Neglect. 21:83-85
As anyone familiar with elder rights issues must know by now, ours is an aging society, one that will continue to grow older well into 2050. Projected along with the burgeoning population of older ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1652ecc661b98b9c396decc4583e1710
https://doi.org/10.1080/08946560802571953
https://doi.org/10.1080/08946560802571953
Publikováno v:
Physical Review B. 92
Measurements of the electrical resistivity, from 1.5 to 300 K, and of the low temperature magnetoresistance of highly conductive carbon nanotube (CNT) fibers, obtained by wet-spinning from liquid crystalline phase (LCP), are reported. At high tempera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fc406854db2a86f552131bf3050d9f9
https://doi.org/10.1103/physrevb.92.085428
https://doi.org/10.1103/physrevb.92.085428
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 158
Eosinophilic otitis media (EOM) is a rare middle ear disease that may closely resemble therapy-resistant otitis media with effusion (OME). The diagnosis is made if eosinophil-rich fluid is present with two or more of the following minor criteria: (a)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::78d64b37556aeceacb4b482d6b5e1a27
https://pubmed.ncbi.nlm.nih.gov/25387983
https://pubmed.ncbi.nlm.nih.gov/25387983
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 158:A8044. Bohn Stafleu van Loghum
BACKGROUND: Eosinophilic otitis media (EOM) is a rare middle ear disease that may closely resemble therapy-resistant otitis media with effusion (OME). The diagnosis is made if eosinophil-rich fluid is present with two or more of the following minor c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::eec30d9ade474af0cbe1aa3650a7e744
https://cris.maastrichtuniversity.nl/en/publications/ae505b51-8c67-4fc0-87e7-b69b59eec11f
https://cris.maastrichtuniversity.nl/en/publications/ae505b51-8c67-4fc0-87e7-b69b59eec11f
Autor:
Robert W. King, Helen Scarnati, Lee Bachelor, Sena Garber, Sylvia Stack, Dean L. Winslow, M. J. Otto
Publikováno v:
Antiviral Research. 28:13-24
The HIV-1 protease (PR) is essential for the production of mature virions. As such, it has become a target for the development of anti-HIV chemotherapeutics. Multiple passages of virus in cell culture in the presence of PR inhibitors have resulted in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db9fb76c3397914e44e919b55d24850
https://doi.org/10.1016/0166-3542(95)00033-i
https://doi.org/10.1016/0166-3542(95)00033-i
Publikováno v:
AIDS Research and Human Retroviruses. 11:107-113
Proviral DNAs from 3 laboratory strains and 21 clinical isolates of HIV-1 were extracted from infected cells after proteinase K digestion and the protease gene was PCR amplified and sequenced directly by the Sanger method. In vitro susceptibilities o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde364c0d1ac6e7ab89070984acc854e
https://doi.org/10.1089/aid.1995.11.107
https://doi.org/10.1089/aid.1995.11.107
Autor:
Hodge Carl Nicholas, Susan Erickson-Viitanen, Y. N. Wong, M. M. Rayner, M. J. Otto, Fernandez Ch, Aldrich Pe
Publikováno v:
Antiviral Chemistry and Chemotherapy. 5:257-262
Low-molecular-weight peptidyl aldehyde inhibitors of HIV protease that reach in vivo plasma concentrations after oral administration substantiailly in excess of the antiviral IC90 are described. We also report efforts to improve the potency and stabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e964180057e59d3025ee9ede9123cd0
https://doi.org/10.1177/095632029400500407
https://doi.org/10.1177/095632029400500407
Autor:
Douglas L. Mayers, Helen Scarnati, James R. Lane, M. J. Otto, Dean L. Winslow, Arlene Bincsik
Publikováno v:
AIDS. 8:753-756
OBJECTIVE: To determine the in vitro susceptibility of primary clinical isolates and laboratory strains of HIV-1 to XM323. METHODS: The AIDS Clinical Trials Group/US Department of Defense p24 antigen-based consensus assay was used to determine in vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f73f457a09a50264e47eb3d9c076ba4
https://doi.org/10.1097/00002030-199406000-00005
https://doi.org/10.1097/00002030-199406000-00005
Autor:
Prabhakar K. Jadhav, Lee Terry Bacheler, B. A. Stone, Jeffrey Allan Miller, M. J. Otto, M. Paul
Publikováno v:
Antiviral Chemistry and Chemotherapy. 5:111-121
A rapid, high-capacity assay for evaluating the potency of anti-HIV compounds was devised. This assay measures cell associated viral RNA levels 3 days after infection of susceptible T-cell lines grown in individual microtitre plate wells. Viral RNA w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b70ff3498729b3ff8ea847e7bc28b61e
https://doi.org/10.1177/095632029400500208
https://doi.org/10.1177/095632029400500208
Autor:
Singh, Sukriti1 sukriti.singh@tuwien.ac.at, García‐Page, Ana1, Noky, Jonathan1, Roychowdhury, Subhajit1,2, Vergniory, Maia G.1,3, Borrmann, Horst1, Klauss, Hans‐Henning4, Felser, Claudia1, Shekhar, Chandra1 shekhar@cpfs.mpg.de
Publikováno v:
Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-10. 10p.